Phase IV safety evaluation of voclosporin in lupus nephritis patients using the FAERS database for a 42-month period (2021 – 2024)
Our findings are consistent with AEs reported in previous clinical trials and outlined in the drug's labeling. The study results further confirm the reliability of the adverse reactions listed in the prescribing information.
Authors
- Bohong Gu (ORCID: https://orcid.org/0000-0003-3797-1081)
- Jia Tang
- Bing Lv (ORCID: https://orcid.org/0000-0002-6483-8684)
Publication Details
- Journal
- International Journal of Clinical Pharmacology and Therapeutics
- Published
- 2025-09-01
- DOI
- https://doi.org/10.5414/cp204726
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00